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Summary 
 
Werner Syndrome is an autosomal recessive disease 
characterized by genomic instability, accelerated 
telomere shortening, and premature aging.  Also, 
Werner Syndrome patients experience increased cancer 
rates, believed to be directly related to the lack of 
interaction between the WRN gene and tumor 
suppressor gene p53. The WRN gene consists of three 
identical molecules and has both exonuclease and 
helicase activity, which work together in opposite 
directions.  WRN has been shown to stimulate 
polymerase β, needed in DNA repair.  WRN helicase 
activity can also bind and degrade G-quadruplexes, 
which inhibit transcription.  Studies show that the tumor 
suppressor gene p53 co-localizes with WRN during the 
S phase, inhibiting the exonuclease activity of WRN, and 
dulling WRN’s helicase ability to unwind Holliday 
Junctions; thus, revealing the regulation of WRN 
function by p53 is important for genomic stability.  WRN 
also interacts with TRF2.  TRF2 binds to DNA, attracts 
WRN, and stimulates the folding over of the 3’ overhang 
of telomeres.  Absence of WRN leads to telomere loss 
and chromosomal fusion which lead to genome 
instability, accumulation of mutations, and thus cancer. 
The lack of WRN leads to premature senescence and 
exhibition of clinical symptoms of aging, even though 
91% of RNA pol II transcription genes are expressed 
similarly to normal aging cells.  The purpose of this 
review is to summarize current literature concerning the 
molecular pathways of Werner Syndrome 
 
Introduction 
 
Werner Syndrome (WS) was discovered in 1903 by Otto 
Werner.  As a student of ophthalmology in Germany, Werner 
noticed peculiar traits among four siblings who were around 
thirty years old (Blachford, 2002).  The specific features he 
noted in these patients were gray hair, cataracts, hair loss, 
and skin abnormalities (Harvard, 2005).  Other common 
pathogenic features of WS include diabetes mellitus, 
osteoporosis, atherosclerosis, systemic sclerosis, increased 
susceptibility to cancer, and other diseases generally 
associated with geriatric patients (Blachford, 2002). 
 Werner Syndrome is an autosomal recessive 
disease exhibiting symptoms of premature aging (Chang, 
2004).  The underlying cause of WS is the absence of the 
WRN gene which was discovered in 1996 by Yu et al.  Since 
then, the Pathology Department of Washington University 
has been working diligently at identifying specific mutations 
of the WRN gene (University of Washington, 2005).  
Although the molecular basis of the disease is still unknown, 
the clinical symptoms and diagnosis of WS are fairly clear. 
 The onset of WS usually occurs between the ages 
of 30 and 40, however, it may be seen in patients as young  
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as 20 (Blachford, 2002).  Although the major onset does not 
occur until later, WS begins to affect patients when they 
hitpuberty, at which point they stop growing, which accounts 
for their small stature and low body mass, and begin to 
display other common features of the disease such as skin 
abnormalities (Blachford, 2002).   
 Other distinguishing pathological hallmarks of WS 
patients that are used for diagnosis are excessive hyaluronic 
acid in the urine; decreased fertility due to impaired gonad 
function and underdeveloped sex organs; and high bone 
density in the phalanges (in contrast with the onset of 
osteoporosis usually seen in WS patients).  Calcium salt 
deposits are also seen, generally in the Achilles, elbow, and 
knee tendons (Blanchford, 2002).   
 Another very important feature of WS patients is 
their increased rate of uncommon cancers (Blanchford, 
2002).  Soft-tissue sarcoma and benign meningioma are two 
such cancers that are relatively prevalent in WS patients 
(Goto, 1996).  The high incidence of cancer is believed to be 
directly related to the absence of interaction between the 
WRN gene and tumor suppressor, p53, in WS patients 
(Blander, 1999). 
 Although Werner Syndrome is not exclusive to any 
race, it is more common among Japanese  people living in 
Japan because of the prevalence of interbreeding (Goto, 
1996).  It is estimated that one in 95,000 to 1,000,000 people 
are affected by WS, but it is difficult to estimate because the 
disease is not usually noticed until adolescence (Blachford, 
2002).  The diagnosis of WS is usually made based on the 
appearance of the three main complications associated with 
the disease which are cataracts, skin abnormalities, and 
small stature, followed by at least two more additional 
symptoms such as osteoperosis, heart problems, or cancer 
(Blanchford, 2002).   
 The prognosis of WS patients is fatal.  Their life 
span is cut short by an average of 30 years, resulting in early 
death usually between the ages of 40 and 47.  Most WS 
patients die as a result of heart complications, cancer, or 
stroke (Blanchford, 2002).  There is currently no cure for 
WS.  The only treatment that may be done is for patients’ 
individual symptoms.   
 Although the molecular mechanisms underlying 
the WRN gene are still unknown, there have been several 
recent discoveries in the roles that WRN fulfills as it interacts 
with other proteins.  Recent studies show that WRN is 
responsible for recruiting several proteins that are necessary 
for proper degradation of certain DNA structures, recognition 
of DNA damage, and the folding over of the 3’ overhang of 
telomeres (Griffith, 1999; Opresko, 2002). 
 
Premature Aging 
 
Aging Basics 
 At the cellular level two primary phenotypes result 
from Werner syndrome—large deletions which cause 
mutations and short proliferative lifespan of cells closely 
associated with a mutation in WRN (Ostler et al., 2000). 
WRN has been found to interact with RPA, an enzyme that 
is required for DNA replication (Opresko et al., 2003). 
 
Telomere loss 
 Aging is linked to telomere lose. In normal aging, 
each year telomeres shorten by 50 base pairs (Rhodes et 
al., 1995). Telomere lose can be corrected with the addition 
of telomerase which extends the telomeres. Several 
independent studies reported that telomerase in WS cells 
 35 
  
 
 
 
Figure 1: This figure depicts the line of events which occur due to the inhibition of helicase/exonuclease activity of WRN.   
The absence of WRN in Werner Syndrome patients prevents several interactions with proteins.  These interactions are necessary for the degradation 
of transcription inhibiting structures and proper repair mechanisms.  Absence of WRN leads to genome instability and characteristic phenotypic traits of 
WS patients. 
 
increases the cellular life span (Opresko et al., 2003). This 
research supports the notation that premature senescence in 
WS cells is related to telomere dysfunction. Human 
telomerase halts the shortening of telomeres, preventing 
senescence in fibroblast, vascular endothelial cells and 
retinal pigmented epithelial cells (Ostler et al., 2000) More 
recently it was suggested that it is the alterations in telomere 
structure, as opposed to telomere length, that was 
responsible for prompting replicative senescence in cells of 
WS patients (Opresko et al., 2003). 
 
Comparison of old genes, young genes and WS genes 
  WS phenotypes are secondary consequences of 
aberrant gene expression and a transcription defect may be 
crucial to the development of the syndrome (Kyng et al., 
2003). Kyng et al. (2003) found that of the 6,912 RNA 
polymerase II transcription genes studied, only 6.3% varied 
when comparing WS or old gene donors to young gene 
donors. Ninety-one percent of annotated genes express 
similar expression changes. Only 3% were unique to WS, 
and 6% were unique to normal aging (Kyng et al., 2003). WS 
cells are deficient in RNA pol II transcription factors which 
are less expressed with age. “Correlating with the increased 
occurrence of cancers in old age and in WS, we found up-
regulation of oncogenes (NDRG1, PIM1, RAB11A, and 
PIK3CA) and down-regulation of tumor suppressor genes 
(ST14, ST16, DKK3, BAP1)” (Kyng et al., 2003). These data 
support the characterization of WS showing the premature 
aging and increased occurrence of cancer as well as provide 
insight to the mechanisms by which these consequences 
occur. 
 
WRN Gene 
The WRN gene, inactive in Werner Syndrome patients, is 
among the RECQ-like family of helicases associated with 
hereditary disorders in humans (Huang et al., 2000).  Of 
these helicases WRN is the only gene in this family known to 
have both helicase and exonuclease ability (Huang et. al 
2000).  The exonuclease domain of the WRN gene lies 
within the first 333 amino acids of a 1432 amino acid chain 
(Opresko et al., 2001), and purified alone has an apparent 
molecular weight of ~40 kDa (Huang et al., 2000).  The full 
WRN gene weighed in at ~170 kDa (Huang et al., 2000).   
 
WRN Helicase/Exonuclease Activity 
 The helicase and exonuclease of WRN act 
together on the same duplex (Opresko et al., 2001).  The 
WRN helicase is active on the forked end of a DNA duplex 
where as the exonuclease activity is active on the blunt end 
of the duplex (Opresko et. al 2001).  However, there seems 
to be no endonuclease activity and the exonuclease activity 
is limited to double stranded DNA with a 5’ overhang as 
opposed to blunt end or single strand DNA (Huang et al., 
2000).  Exonuclease can also act on nicks or gaps in a DNA 
duplex.  The exonuclease activity can successfully remove 
terminal mismatched nucleotides, but as the number of 
mismatches increase the exonuclease acts less efficiently.  
After a maximum of six terminal mismatched nucleotides, 
exonuclease activity was nearly undetectable (Huang et al., 
2000).  The termination of exonuclease activity would then 
result in an accumulation of mutations and thus cancer.   
Aside from the nature of the duplex, the length 
also affected both activities of WRN; the exonuclease activity 
was greater on longer duplexes that were not unwound by 
the helicase, but there was less activity on shorter duplexes 
unwound by the helicase activity (Opresko et al., 2001).  
Because inactivation of the helicase activity showed a 
greater extent of exonuclease digestion, the WRN 
exonuclease activity seems to be regulated by the rapid 
unwinding of a duplex by the helicase activity.   
It has been suggested that WRN binds to forked 
duplexes where the helicase starts unwinding at the forked 
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end and the exonuclease shortens the strand from the 
opposite end.  The WRN will continue to bind to the duplex 
until the exonuclease digestion shortens the strand to an 
unstable length and the duplex dissolves (Huang et al., 
2000).  This suggests that when there are long segments of 
DNA that cannot be unwound by the helicase alone, both 
activities work together to remove the segments.   
 
Oligomerization State of WRN 
 Although the oligomerization state of a 
helicase/exonuclease my not seem important, as we know 
structure equals function.  WRN is a trimer.  It is a complex 
made of three identical molecules, whereas many other 
helicases are hexamers including the BLM helicase 
associated with the related disease Blooms Syndrome.  
Because of this oligomerization state, it is possible for WRN 
to interact with other trimers such as Proliferating Cell 
Nuclear Antigen (PCNA).   This interaction may be 
significant in halting the cell cycle and preventing 
proliferation. 
 
WRN and DNA Repair 
 WRN interacts with a variety of proteins involved 
in DNA repair, for example, PCNA, RPA, and FEN-
1(Harrigan et al., 2003). PCNA is part of a sliding clamp that 
forms a ring that maintains the connection of polymerase to 
its DNA template allowing uninterrupted synthesis (Cooper, 
2000).  WRN has been shown to have a direct interaction 
with PCNA in vitro, suggesting a unique role for WRN in 
DNA synthesis (Huang et al., 2000).  RPA stimulates WRN 
helicase to unwind substrates that WRN cannot unwind 
alone (Harrigan et al., 2003).  FEN-1 also physically interacts 
with WRN which stimulates its DNA flap cleavage activity 
(Harrigan et al., 2003).  However, physical interaction does 
not give enough information to show a relationship relative to 
DNA synthesis or repair.   
 On the other hand, WRN has been found to 
physically interact with polymerase β (pol  β), another protein 
involved in DNA repair.  DNA polymerase β is essential for 
long and short patch base excision repair (BER), which is 
important in repairing DNA damaged by oxidized, alkylated, 
deaminated, and hydrolyzed bases (Harrigan et al., 2003).  
Within this physical interaction, pol β has no effect on WRN 
helicase or exonuclease activities, however, WRN has been 
shown to stimulate pol β DNA strand displacement synthesis 
(Harrigan et al., 2003).  Because the presence of WRN 
increased the products of strand displacement, this suggests 
that WRN stimulates long patch BER by pol β (Harrigan et 
al., 2003).   
 
MYC interaction with WRN 
 MYC oncoprotein coordinates both cell growth and 
division. In the cell with WRN, MYC stimulates transcription 
of the gene. WRN depletion from control fibroblasts led to 
rapid cellular senescence that could not be suppressed by 
hTERT expression (Grandori et al., 2003).  The expression 
of hTERT would have been expected to result in the cell 
evading senescence. The increase of MYC in a cell 
increases the amount of WRN in the cell. Neither MYC nor 
WRN are differentiated cells and thus proliferate frequently. 
When TPA (tissue plasminogen activator) was added the 
leukemia cell lines, produced of MYC and WRN were down-
regulated (Grandori et al., 2003). 
 
WRN Helicase and Substrate Specificity 
 RecQ helicases, like WRN, have a common 
helicase domain which will bind and hydrolyze ATP.  Two of 
these domains are the RecQ C-terminal region (RQC) and a 
helicase RNase D C-terminal (HRDC) domain (Opresko et 
al., 2004).  These domains located on WRN helicase are 
known to bind to various DNA substrates and facilitate other 
DNA metabolic pathway steps (Opresko et al., 2004).  The 
substrates explored, were blunt-end duplexes, tailed 
duplexes, 12nt bubbles, X-junctions, D-loops, and G-
quadruplexes. 
 
WRN and DNA duplexes 
 Substrate specificities of WRN helicase were 
tested on DNA blunt end duplexes of 25bp and 50bp.  There 
were no measurable levels of DNA unwinding by WRN 
(Mohaghegh et al., 2001).  Concentration levels of WRN 
helicase that actually unwound the blunt-end duplexes were 
much higher than in any other parts of the experiment where 
WRN successfully unwound substrates.  It was also found 
that WRN does not have a high affinity for 3’- or 5’-tailed 
DNA duplexes when compared to other substrates tested 
(Mohaghegh et al., 2001). This suggests that WRN helicase 
activity is low to non-existent in the presence of DNA 
duplexes. 
 
WRN and Synthetic X-junctions and Bubble Structures 
 Synthetic X-structures are models for the Holliday 
junction recombination intermediates (Li et al., 2001).  These 
substrates were thus tested, because they could link WRN to 
playing a role in recombination.  Experiments results indicate 
that WRN is able to unwind these junctions relatively well 
and 12 nucleotide bubble structures were unwound 
efficiently (Mohaghegh et al., 2001).  These two findings 
when compared to the lack of unwinding of blunt-end 
duplexes possibly point to the conclusion that internal 
structural features are required in DNA to initiate unwinding 
(Mohaghegh et al., 2001). 
 
WRN and D-loops 
 Another study was conducted to examine the 
interaction between WRN helicase and D-loop structures.  
The D-loop structure is the junction between the single- and 
double-stranded DNA and the available 3’ end (Orren et al., 
2002).  D-loop substrates are thought to be an intermediate 
structure that forms during recombination pathways (Orren 
et al., 2002).  They found that WRN does have a high affinity 
for binding and metabolizing D-loop structures.  This may 
correlate with the idea that internal structural features are 
needed to initiate in unwinding (Mohaghegh et al., 2001).  
These results also indicate that both the helicase and 
exonuclease activities working together make this metabolic 
process more efficient (Orren et al., 2002).   
 
WRN and G-quadruplexes 
 G-quadruplexes are guanine rich structures 
thought to play a role in processes like DNA replication, 
transcription, and recombination.  The formation of G-
quadruplexes is known to inhibit DNA replication (Li et al., 
2001).  Experimental evidences shows that WRN helicase is 
capable of degrading G-quadruplex substrates with very high 
affinity compared to all of the other substrates examined.  
This finding adds to the theory that an internal structural 
feature must be present to initiate unwinding.  Without the 
helicase activity of WRN on the G-quadruplex and inhibition 
of DNA replication in WS patient cells, the 3’ end is 
recognized as a mutation resulting in senescense.  
 
 
Telomeres and Helicase Activity 
 Research on the pathogenesis of Werner 
Syndrome has recently been a prominent focus in biology.  
In particular, scientists have been focusing on the role of 
telomere structure and the presence or lack of helicase.  
Past research on the link between telomeric structure, 
helicase, and genomic instability have led to telomeres 
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posing as one of the main focal points in the search for the 
link between telomere length and pathogenic phenotypes 
(Chang et al., 2004). 
 The need for stable telomeres is an integral part of 
the body’s defense against an accumulation of mutations 
that may lead to cancer.  When the normal function of the 
telomere is disrupted and doomed to become shorter and 
shorter, as in Werner Syndrome patient cells, a likely result 
is cancer (Opresko et al., 2004).   
 
Telomere Shortening and Fusion 
 The association of Werner Syndrome and 
telomere dysfunction has been established.  Recent in vivo 
studies on a mouse model have shown that mice with long 
telomeres but lack the WRN gene do not display the 
phenotypic characteristics of WS.  In their study, Chang et 
al., produced several generations of WRN deficient mice 
intercrossed with TERC deficient mice.  This produced 
shorter and shorter telomeres through successive 
generations along with increased pathogenesis.  Pathogenic 
phenotypes were not seen in the G5-G6 generations of 
TERC-/- WRN+/+ mice as they were in TERC-/- WRN-/- of the 
same generation and age.  The WRN deficient mice of the 
G5-G6 generation also expressed chromosomal fusion of 
the p-p arm and accelerated shortening of the telomeres 
(2004). Another similar study of the mouse model by, Du et 
al. (2005), provided results that agree with those of Chang et 
al. (2004).  In addition, Du presented an idea based on the 
data showing that telomerase is able to compensate for 
some problems caused by helicase deficiency.  The fact that 
WRN deficiency affects primarily cells that have slow 
replication rates and low levels of telomerase activity, 
suggest that the turnover rates are high enough to cause 
telomere shortening as they age. However, telomerase 
activity is too low to compensate for this loss and prevent 
telomere dysfunction (Du et al., 2005).   
 
Cancer 
 The high incidence of cancer in WS patients is due 
to genomic instability.  Although the exact pathways of WRN 
and the tumor suppressor protein p53 are not known, there 
is evidence to suggest that the interaction of the two has 
clear implications for the high incidence of cancer. 
 p53 is responsible for halting the cell cycle in both 
G phases so that damaged DNA may be repaired.  
Therefore, without p53 action there is increased genomic 
instability (Mohaghegh et al. 2001).  The expression of p53 
action is decreased in WS patient cells because p53 and 
WRN seem to have to interact for p53 to function properly 
(Opresko et al., 2004).   
  The speculated links between p53 expression, 
WRN, genomic instability, and cancer are thus logical.  
Without the WRN, p53 does not recognize damaged DNA 
that needs to be repaired.  Lack of damage control leads to 
genomic instability and an accumulation of mutations, which 
result in cancer.  
  
TRF2 and Helicase Activity 
 TRF2 is a protein that binds to and maintains 
telomeres throughout the cell cycle (Opresko et al., 2004).  
TRF2’s importance lies in its function as a promoter for the 
helicase activity of WRN (Opresko et al., 2004).  Therefore, 
with the absence of WRN in WS patients, TRF2 is unable to 
perform its duty and telomeric specific structures that need 
to be degraded remain.  These structures then act as 
barriers against various transcription factors and telomeres 
are left without being fully transcribed.  Therefore, the result 
is incomplete telomeres which leads to genomic instability 
and cancer. 
 TRF2 is believed to directly interact with the WRN 
protein.  TRF2 first binds to the double-stranded telomere 
regions of DNA.  WRN, which has a high affinity for TRF2, 
then binds to the TRF2 .  The interaction between WRN and 
TRF2 may serve to stabilize TRF2 in its active form or to 
improve TRF2’s interaction with DNA (Opresko et al., 2002).  
If the enzyme is able to bind to the telomere sequence and 
attract WRN, the nature of WRN to act as a helicase will 
prepare the telomere sequence for transcription. 
 Another important role that TRF2 is believed to 
play in telomere functionality involves t loops.  T loops are 
the formations at the end of telomeres created when the 3’ 
overhang bends back on itself to close the end of the DNA.  
TRF2 is believed to facilitate this folding over behavior 
(Griffith et al., 1999).  Appropriate functioning of this 
mechanism is necessary for the capping of chromosomes.   
 In WS patients the WRN gene is absent.  Because 
TRF2 must work with WRN to do its job, in the absence of 
WRN, TRF2 is inhibited.  When TRF2 is inhibited, t loops do 
not form and the ends of the chromosomes are left 
uncapped.  Inhibition of TRF2 also leads to the activation of 
a DNA damage checkpoint pathway.  Therefore, when the 
incomplete (uncapped) telomere is checked it will be 
recognized as damaged DNA, leading to cessation of the 
cell cycle and apoptosis (Griffith et al., 1999). 
 
WRN and Genomic Instability 
 A number of studies suggest that defects in the 
processes of DNA replication, repair, recombination, or a 
combination of these pathways are responsible for the 
genomic instability of WS (Brosh et al., 2002).  The tumor 
suppressor gene p53 has been found to play a critical role in 
maintaining genomic integrity by interacting with WRN in two 
different ways (Brosh et al., 2001).  The interaction between 
WRN and FEN-1, a DNA structure-specific nuclease, has 
also been found important in the maintenance of genomic 
stability (Brosh et al., 2002). 
 
p53 and WRN Exonuclease Activity 
To investigate the relationship between p53 and 
WRN, the effect of p53 protein on WRN exonuclease was 
tested.  It was discovered that p53 effectively inhibits WRN 
exonuclease activity (Brosh et al., 2001).  More specifically, 
p53 inhibits the exonuclease activity of the full-length WRN 
protein by binding the carboxyl-terminal region (Brosh et al., 
2001).  Thus the modulation of WRN exonuclease activity by 
p53 is dependent on protein interaction and likely to be 
influenced by the DNA binding properties of p53 (Brosh et 
al., 2001).  
There are likely biological consequences of 
inhibiting WRN exonuclease activity.  Brosh et al. (2001) 
found that WRN exits the nucleolus and colocalizes with p53 
in the nucleoplasm when cells were arrested in S phase.  
This suggests that WRN and p53 may be associated with 
the DNA replication complex.  The interaction of p53 and 
WRN might be important to direct S-phase cells into 
apoptosis (Brosh et al., 2001).  
The weaken level of p53-mediated apoptosisin 
WS cells might be explained by the absence of WRN-p53 
interaction (Brosh et al., 2001).  This interaction might serve 
as a signal for programmed cell death.  Suggesting that p53 
modulation of WRN exonuclease activity may be critical for 
p53-mediated apoptosis. 
 
p53 and WRN Helicase Activity 
WRN unwinds Holliday junctions (HJ), reducing 
inappropriate DNA recombination (Yang et al., 2002).  
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Figure 2: Proper transcription and capping of telomeres is essential for normal functioning of the telomere.  
The colocalization of WRN with both TRF2 and p53 leads to proper capping of the telomere and its genetic stability. Absence of WRN, 
therefore lead to genetic instability and a heightened predisposition to cancer
 
Homologous recombination (HR) is an important 
process that repairs DNA damage that occurs during 
nearly every round of DNA replication.  It was found 
that p53 modulates the ability of WRN helicase to 
disrupt HJ (Yang et al., 2002).  It was also found that 
p53 phosphorylation, its inactive form, will decrease 
unmodified p53 inhibition of WRN helicase activity, 
allowing WRN to function properly (Yang et al., 2002).  
These data suggest that p53 plays a functional role in 
the helicase-HR pathway. 
 
WRN and FEN-1 
 FEN-1 is a DNA structure-specific nuclease 
implicated in pathways of DNA metabolism that are 
important for genomic stability (Brosh et al., 2002).  To 
understand the potential importance of the WRN – 
FEN-1 interaction in DNA replication, the effect of WRN 
on FEN-1 cleavage was tested.  Brosh et al. (2002) 
found that WRN stimulates FEN-1 cleavage activity, but 
not when there is a fold-back flap structure.  This study 
also showed that the ability of WRN to stimulate FEN-1 
cleavage is optimal under conditions in which WRN 
does not unwind the 5’ flap structure (Brosh et al., 
2002).  Stimulation of FEN-1 cleavage of 5’ flaps may 
be important in Okazaki fragment processing during 
lagging strand synthesis at the replication fork (Brosh et 
al., 2002).  Delayed action of FEN-1 cleavage of these 
fragments may be harmful due to the millions of them 
that get produced each time the genome is replicated.  
Defected Okazaki fragment processing causes double 
strand breaks which may lead to genomic instability in 
WS (Brosh et al., 2002). 
 
Conclusion 
 
Werner syndrome is an autosomal recessive disease 
that is characterized by premature aging and genomic 
instability. The gene thought responsible for the 
characteristics shown in Werner patients has both 
helicase and exonuclease activity.  WRN helicase is 
highly substrate specific mainly for D-loop structures 
and G-quadruplexes suggesting that internal structures 
are required for DNA unwinding.  The exonuclease 
activity works together with the helicase to unwind and 
remove terminal nucleotides.   WRN also associates 
with repair proteins suggesting a unique role for the 
WRN gene in DNA repair.  WRN is also associated with 
accelerated telomere loss and premature aging. 
Telomere shortening and chromosomal fusion form the 
basis of genomic instability that leads to cancer.  The 
co-localization of the WRN gene and the telomere 
maintenance protein TRF-2 stimulate helicase activity. 
 WRN also co-localizes with p53 which inhibits 
exonuclease activity and dulls WRN helicase ability to 
unwind inappropriate DNA structures.  The symptoms 
of aging and genomic instability that Werner Syndrome 
patients exhibit require the loss of function in the WRN 
gene and the WRN gene and the protein it produces 
have been found to be important in many factors of 
DNA maintenance,.  If this gene were replaced or 
became functioning in WS patients, the chances of 
getting  WS  would  be  minimal.   To  further  study this  
conclusion, experiments using a knockout WRN gene 
and an added normal functioning WRN gene are 
necessary.  Because there have only been studies 
done in vitro with the WRN gene and its functioning in 
WS, the next step is to study the function of this 
important gene in vivo.   
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